DEF 14AThe Ballot
Outlook Therapeutics, Inc. files DEF 14A
Filed Feb 15, 2023 · 3y ago · Accession 0001104659-23-022226
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Outlook Therapeutics, Inc.
- Ticker
- OTLK
- CIK
- 1649989
- Form type
- DEF 14A
- Filing date
- Feb 15, 2023
- Report date
- Mar 29, 2023
- Document
- tm233330-2_def14a.htm
- Size
- 2.7 MB